Overview

Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers

Status:
RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
A Phase 1, Open-Label Study to Assess Pharmacokinetics, Safety and Tolerability of G1090N in Healthy Subjects
Phase:
PHASE1
Details
Lead Sponsor:
Genfit